Investor insights
Sectors invested in
Biotechnology2
Medical Device1
Medical1
#IL171
#HS1
#PsA1
#Nanobody1
Immunotherapy1
#MLTX1
IL17A / F1
inflammatory skin & joint diseases1
partnering1
Funding rounds participated in
$98M sweet spot round size
Most of their 2 investments are in rounds between $80M and $115M
Investor type
Venture Capital
Basic info
Industry
investment management
Date founded
2012
Investments made
M
MoonLake Immunotherapeutics AG raised $115M on April 6, 2022
Investors: RTW Investments, LP, Surveyor Capital, Tekla Capital Management, Monashee Investment Management LLC and Asymmetry Capital Management, L.P.
D
DiCE Molecules raised $80M on January 8, 2021
Investors: Sanofi Ventures, Soleus Capital Management, L.P., Osage University Partners (OUP), Northpond Ventures, RA Capital Management, L.P., New Leaf Venture Partners, Driehaus Capital Management LLC, Eventide Asset Management, Sands Capital Management and Asymmetry Capital Management, L.P.